Hypertension, Vol 22, 214-220, Copyright © 1993 by American Heart Association
JD Peuler, BA Johnson, SM Phare and JR Sowers
Glyburide, an insulin secretagogue and an insulin-sensitizing agent, lowers
blood pressure in normal male and female dogs when administered acutely.
Because insulin resistance may contribute to spontaneous hypertension in
rats, we sought to determine if long-term administration of glyburide (5
mg/kg per day by diet, age 5 weeks to 5 months) would lower blood pressure
in male and female stroke-prone spontaneously hypertensive rats. Arterial
(aortic) rings from these rats were incubated with insulin in vitro (100
mU/mL) 1 hour before and during phenylephrine-induced contraction to
determine if long-term glyburide administration improves vascular
sensitivity to the intrinsic vasodilator action of insulin. Glyburide,
however, significantly increased blood pressures and ratios of heart weight
to body weight in 5-month-old female rats (+20 mm Hg diastolic, P <
.05), with no significant change noted in male rats (+4 mm Hg diastolic).
Glyburide increased plasma insulin levels (twofold, P < .04) in female
but not in male rats. Glyburide did not affect plasma glucose or
catecholamine levels. After incubation with insulin, aortic to rings from
glyburide- treated female rats demonstrated more than 40% greater
contractile responsiveness the phenylephrine compared with aortic rings
from control female rats (P < .04). This insulin-dependent increase in
phenylephrine-induced contraction consisted of a reversal in the in vitro
action of insulin, from attenuation to accentuation of such contraction (P
< .05). This change was not seen in male rats. Neither gender,
glyburide, nor insulin influenced acetylcholine-induced relaxation of
phenylephrine-induced contraction.(ABSTRACT TRUNCATED AT 250 WORDS)
ARTICLES
Sex-specific effects of an insulin secretagogue in stroke-prone hypertensive rats
Department of Internal Medicine, Wayne State University School of Medicine, VA Medical Center, Detroit, Mich.
This article has been cited by other articles:
![]() |
J. D. Peuler Opposing adrenergic actions of intravenous metformin on arterial pressure in female spontaneously hypertensive rats Cardiovasc Res, July 1, 1999; 43(1): 237 - 247. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Vecchione, C. Morisco, L. Fratta, L. Argenziano, B. Trimarco, and G. Lembo Dietary Sodium Restriction Impairs Endothelial Effect of Insulin Hypertension, June 1, 1998; 31(6): 1261 - 1265. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. T. Stepniakowski, G. Lu, G. D. Miller, and B. M. Egan Fatty Acids, Not Insulin, Modulate {alpha}1-Adrenergic Reactivity in Dorsal Hand Veins Hypertension, November 1, 1997; 30(5): 1150 - 1155. [Abstract] [Full Text] |
||||
![]() |
J. R. Sowers Insulin and Insulin-Like Growth Factor in Normal and Pathological Cardiovascular Physiology Hypertension, March 1, 1997; 29(3): 691 - 699. [Full Text] |
||||
![]() |
T. A. Kotchen Attenuation of Hypertension by Insulin-Sensitizing Agents Hypertension, August 1, 1996; 28(2): 219 - 223. [Full Text] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1993 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |